biomarker validation | GenomeWeb

biomarker validation

The companies will develop biomarkers of response to Lantern's lead therapy candidates, including a potential liquid biopsy assay for its NSCLC drug Tavocept.

The study, called Panfam-1, will analyze 1,000 individuals at high risk of familial pancreatic cancer over three years using the company's antibody array test.

The partners will evaluate new biomarkers that they both find, and will assess the possibility for a preterm birth prognostic panel.

Caris Life Sciences also found that time-to-next treatment could be a surrogate endpoint for survival.

The researchers were able to differentiate among patients with lung cancer, COPD, and health controls using the biomarkers.

Fresh off of a $15 million private placement and restructuring transaction intended to simplify its capital structure, WaferGen Biosystems has shifted its focus to position itself as a provider of tools to supplement next-generation sequencing.

NEW YORK (GenomeWeb News) – UK cancer biomarker firm Abcodia today announced a collaboration with the Austrian Institute of Technology to validate biomarkers for the early detection of lung and colorectal cancers.

NEW YORK (GenomeWeb News) – Genomic test development firm GenomeDx today announced an expanded research agreement with the Mayo Clinic to include the exclusive licensing of certain Mayo IP.

Pages

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.